{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zolpidem-matched+placebo", "query": { "intervention": "Zolpidem-matched placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zolpidem-matched+placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T13:27:56.301Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05540574", "title": "Trial of Zolpidem for Sleep in Children With Autism", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism", "Autism Spectrum Disorder" ], "interventions": [ { "name": "Zolpidem", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 26, "start_date": "2023-08-09", "completion_date": "2028-04-30", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05540574" }, { "nct_id": "NCT01463098", "title": "A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "E2006 1.0 mg", "type": "DRUG" }, { "name": "E2006 2.5 mg", "type": "DRUG" }, { "name": "E2006 5.0 mg", "type": "DRUG" }, { "name": "E2006 10.0 mg", "type": "DRUG" }, { "name": "E2006 25.0 mg", "type": "DRUG" }, { "name": "E2006 50.0 mg", "type": "DRUG" }, { "name": "E2006 100 mg", "type": "DRUG" }, { "name": "E2006 200 mg", "type": "DRUG" }, { "name": "Zolpidem 10 mg", "type": "DRUG" }, { "name": "E2006 Matched Placebo or Zolpidem Matched Placebo", "type": "DRUG" }, { "name": "E2006 Matched Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 122, "start_date": "2011-10-05", "completion_date": "2012-08-11", "has_results": true, "last_update_posted_date": "2020-01-18", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 2, "location_summary": "New York, New York • Cincinnati, Ohio", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01463098" }, { "nct_id": "NCT02839200", "title": "Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Insomnia Disorder" ], "interventions": [ { "name": "ACT-541468 5 mg", "type": "DRUG" }, { "name": "ACT-541468 10 mg", "type": "DRUG" }, { "name": "ACT-541468 25 mg", "type": "DRUG" }, { "name": "Zolpidem", "type": "DRUG" }, { "name": "Placebo 1", "type": "DRUG" }, { "name": "Placebo 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idorsia Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 360, "start_date": "2016-10-04", "completion_date": "2017-06-20", "has_results": true, "last_update_posted_date": "2020-04-13", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 15, "location_summary": "Santa Monica, California • Upland, California • Brandon, Florida + 12 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02839200" }, { "nct_id": "NCT03657355", "title": "Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Recreational Drug Users" ], "interventions": [ { "name": "ACT-541468", "type": "DRUG" }, { "name": "Suvorexant", "type": "DRUG" }, { "name": "Zolpidem", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idorsia Pharmaceuticals Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 63, "start_date": "2018-09-07", "completion_date": "2019-08-08", "has_results": false, "last_update_posted_date": "2019-09-19", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03657355" }, { "nct_id": "NCT03375203", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Insomnia Disorders" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "JNJ-42847922, 5 mg", "type": "DRUG" }, { "name": "JNJ-42847922, 10 mg", "type": "DRUG" }, { "name": "JNJ-42847922, 20 mg", "type": "DRUG" }, { "name": "Zolpidem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 365, "start_date": "2017-11-23", "completion_date": "2019-04-03", "has_results": true, "last_update_posted_date": "2025-04-29", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Rogers, Arkansas • Anaheim, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03375203" }, { "nct_id": "NCT00784875", "title": "An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Insomnia", "Secondary Insomnia" ], "interventions": [ { "name": "LY2624803", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "zolpidem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 643, "start_date": "2008-10", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2012-02-29", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 49, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784875" }, { "nct_id": "NCT02783729", "title": "Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "Lemborexant", "type": "DRUG" }, { "name": "Lemborexant-matched placebo", "type": "DRUG" }, { "name": "Zolpidem tartrate", "type": "DRUG" }, { "name": "Zolpidem-matched placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 1006, "start_date": "2016-05-31", "completion_date": "2018-01-30", "has_results": true, "last_update_posted_date": "2024-11-12", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 60, "location_summary": "Jasper, Alabama • Glendale, Arizona • Little Rock, Arkansas + 49 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carlsbad", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02783729" }, { "nct_id": "NCT00492232", "title": "Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Insomnia" ], "interventions": [ { "name": "Ramelteon and zolpidem", "type": "DRUG" }, { "name": "Placebo and zolpidem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2007-04", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2010-07-20", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 41, "location_summary": "Hot Springs, Arkansas • Anaheim, California • Fountain Valley, California + 38 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00492232" }, { "nct_id": "NCT03008447", "title": "Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "LEM5", "type": "DRUG" }, { "name": "LEM10", "type": "DRUG" }, { "name": "ZOL", "type": "DRUG" }, { "name": "PBO", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 60, "start_date": "2016-11-21", "completion_date": "2018-01-03", "has_results": false, "last_update_posted_date": "2019-08-01", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 4, "location_summary": "Atlanta, Georgia • New York, New York • Raleigh, North Carolina + 1 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03008447" }, { "nct_id": "NCT00568789", "title": "Safety of Ramelteon in Elderly Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Insomnia" ], "interventions": [ { "name": "Ramelteon, zolpidem and placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 33, "start_date": "2006-06", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2012-02-28", "last_synced_at": "2026-09-24T13:27:56.301Z", "location_count": 6, "location_summary": "Costa Mesa, California • San Diego, California • Miami, Florida + 3 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00568789" } ] }